OP0193 BIIB059, A HUMANIZED MONOCLONAL ANTIBODY TARGETING BDCA2 ON PLASMACYTOID DENDRITIC CELLS (PDC), SHOWS DOSE-RELATED EFFICACY IN THE PHASE 2 LILAC STUDY IN PATIENTS (PTS) WITH ACTIVE CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)

Victoria P. Werth, Richard Furie, Juanita Romero‐Díaz, Sandra Navarra, Kenneth Kalunian, Ronald van Vollenhoven, Fredrik Nyberg, Benjamin H. Kaffenberger, Saira Z. Sheikh, Goran Radunović, Xianping Huang, Hua Carroll, François Gaudreault, Adam L. Meyers, Catherine Barbey, Cristina Musselli, Nathalie Franchimont